Opendoor Forecasts 18% 2025 Revenue Drop to $4.2 B as AI Expansion Begins
Opendoor's shares rallied from a $0.51 May low to nearly $7, yet remain 80% below the $35.88 peak. Analysts project 2025 revenue down 18% to $4.2 billion with negative 1.9% EBITDA margin; they expect 15% revenue growth and breakeven adjusted EBITDA by 2027 under CEO Kaz Nejatian’s AI-driven pricing and expansion.
1. Massive Rally from Lows Highlights Upside Potential
Opendoor’s share price surged more than 1,200% from its May low of $0.51, turning a $1,000 investment into over $13,000 in just seven and a half months. Despite that run, the stock remains roughly 80% below its February 2021 peak of $35.88, trading at just 1.5 times projected 2025 sales. This valuation gap suggests significant upside if growth reaccelerates and investor sentiment improves.
2. Near-Term Headwinds and Strategic Overhaul
Revenue fell from $15.6 billion in 2022 to an estimated $4.2 billion for full-year 2025, while adjusted EBITDA margins have stayed negative, most recently near -1.1% through nine months. Net losses have narrowed from $1.4 billion in 2022 to a projected $297 million in 2025. To reverse this trend, Opendoor installed Kaz Nejatian, former Shopify COO, as CEO and bolstered its board, while quantitative trading firm Jane Street took a 5.9% stake. Management is upgrading AI pricing models, expanding a direct buyer-seller marketplace and forging partnerships with major homebuilders and online real estate platforms to diversify beyond its capital-intensive home-flipping unit.
3. Path to Multibagger Returns Over the Next Decade
Analysts forecast revenue growth of 15% in 2026 and 41% in 2027 as mortgage rates moderate and housing demand rebounds, with full-year adjusted EBITDA turning positive by 2027. If Opendoor sustains a 20% compound annual revenue growth rate from 2028 to 2035 and achieves a three‐times‐sales valuation multiple, its market capitalization could expand to about $88 billion—more than 13 times today’s level. Execution risks remain high, but successful diversification into higher-margin services could unlock substantial long-term returns for patient investors.